Recent data from the ATAC Arimidex, Tamoxifen Alone or in Combination randomized trial indicate that anastrozole significantly reduces breast cancer recurrence rates but does not provide any advantage in terms of survival at 4 years posttreatment <a href=https://stromectol.ink/>stromectol online apotheke</a> BMJ, 2014, 348 g2545